# Correction to: Erythropoietin Abrogates Post-Ischemic Activation of the NLRP3, NLRC4, and AIM2 Inflammasomes in Microglia/Macrophages in a TAK1-Dependent Manner

**Authors:** Ole Heinisch, Thomas Zeyen, Tobias Goldmann, Marco Prinz, Michael Huber, Jennifer Jung, Eren Arik, Shahin Habib, Alexander Slowik, Arno Reich, Jörg B. Schulz, Pardes Habib

PMC · DOI: 10.1007/s12975-023-01156-2 · Translational Stroke Research · 2023-06-22

## Full-text entities

- **Genes:** MAP3K7 (mitogen-activated protein kinase kinase kinase 7) [NCBI Gene 6885] {aka CSCF, FMD2, MEKK7, TAK1, TGF1a}, NLRC4 (NLR family CARD domain containing 4) [NCBI Gene 58484] {aka AIFEC, CARD12, CLAN, CLAN1, CLANA, CLANB}, AIM2 (absent in melanoma 2) [NCBI Gene 9447] {aka PYHIN4}, NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548] {aka AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1}, EPO (erythropoietin) [NCBI Gene 2056] {aka DBAL, ECYT5, EP, MVCD2}

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11106097/full.md

---
Source: https://tomesphere.com/paper/PMC11106097